全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Menghan Zhu , Nan Jia , Feifei Huang ...
来源:[J].BMC Cancer(IF 3.333), 2017, Vol.17 (1)Springer
摘要:Our research aimed to investigate whether lymphadenectomy was required in patients with intermediate-risk endometrioid endometrial cancer (EEC).
作者:Wenze Sun , Tao Wang , Fan Shi ...
来源:[J].BMC Cancer(IF 3.333), 2015, Vol.15 (1)Springer
摘要:Abstract(#br) Background(#br)In cervical cancer patients with intermediate-risk factors, the optimal adjuvant therapy is still controversial. We undertook a randomized trial (ClinicalTrials.gov Identifier: NCT01418859) to compare the efficacy and toxicity of concurrent chemoradio...
作者:Bernardette Bonello , Alex Ghanouni , Harriet L. Bowyer ...
来源:[J].BMC Gastroenterology(IF 2.11), 2016, Vol.16 (1)Springer
摘要:Abstract(#br) Background(#br)To assess public preferences for colorectal cancer (CRC) surveillance tests for intermediate-risk adenomas, using a hypothetical scenario.(#br) Methods(#br)Adults aged 45–54 years without CRC were identified from three General Practices in England...
作者:Stefano Bracci , Mattia F. Osti , Linda Agolli ...
来源:[J].Radiation Oncology(IF 2.107), 2016, Vol.11 (1)Springer
摘要:Abstract(#br) Background(#br)to evaluate the role of a risk stratification system in intermediate-risk prostate cancer (PCa) treated with hypofractionated radiotherapy (HyRT).(#br) Methods(#br)131 patients affected by intermediate-risk PCa were treated with HyRT at the total...
作者:Elise Deluche , Laurence Venat-Bouvet , Sophie Leobon ...
来源:[J].BMC Cancer(IF 3.333), 2017, Vol.17 (1)Springer
摘要:The objective of this study was to compare the efficacy of biomarkers in assessing the risk of breast cancer recurrence in patients with node-negative or micrometastatic grade II breast cancer. Specifically, we compared risk assessments based on the St. Gallen clinicopathological...
作者:Annelies Gonnissen , Sofie Isebaert , Christiaan Perneel ...
来源:[J].BMC Cancer(IF 3.333), 2017, Vol.17 (1)Springer
摘要:Prostate cancer (PCa) is a heterogeneous disease with a variable natural history, genetics, and treatment outcome. The Hedgehog (Hh) signaling pathway is increasingly recognized as being potentially important for the development and progression of PCa. In this retrospective study...
作者:Ahmed E. Abugharib , Robert T. Dess , Payal D. Soni ...
来源:[J].Brachytherapy(IF 1.22), 2017, Vol.16 (4), pp.782-789Elsevier
摘要:Abstract(#br)Purpose(#br)To compare the tumor control and toxicity in men with intermediate-risk prostate cancer treated with either external beam radiation therapy (EBRT) or EBRT plus low-dose-rate brachytherapy (combo-RT).(#br)Methods and Materials(#br)Between 1995 and 2012...
作者:Bian-Hong Wang , Yong-Hui Li , Li Yu
来源:[J].Chinese Medical Journal(IF 0.901), 2015, Vol.128 (17), pp.2395-2403DOAJ
摘要:Objective: Intermediate-risk acute myeloid leukemia (IR-AML), which accounts for a substantial number of AML cases, is highly heterogeneous. We systematically summarize the latest research progress on the significance of gene mutations for prognostic stratification of IR-AML.Data...
作者:Meng Li , Mengyang Hu , Yuanjian Wang ...
来源:[J].European Journal of Obstetrics & Gynecology and Reproductive Biology(IF 1.843), 2019, Vol.238, pp.1-6Elsevier
摘要:... The treatment regimen for patients with intermediate-risk factors, however, remains unclear. We, thus, performed a systematic review and meta-analysis to assess the recurrence-free survival (RFS), overall survival (OS), grade III/IV hematologic toxicity and grade III/IV n...
作者:Guang-yuan Gao , Ping Yang , Miao Liu ...
来源:[J].Thrombosis Research(IF 3.133), 2015, Vol.136 (5), pp.932-937Elsevier
摘要:Abstract(#br)Background(#br)The use of thrombolytic therapy in patients with intermediate-risk pulmonary embolism is controversial. To compare with anticoagulation alone, no analysis before has determined whether thrombolytic therapy is associated with improved survival or lower...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×